Kura Oncology annual operating income
2010
2011
2012
2013
2014
2022
2023
2024
2025
Kura Oncology Operating Income Growth & History (KURA)
Kura Oncology's operating income was −$303.6M for fiscal 2025.
View full Kura Oncology company overviewKura Oncology annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$303.6M | −$110.4M | — |
| 2024 | 2024-12-31 | −$193.2M | −$27.4M | — |
| 2023 | 2023-12-31 | −$165.8M | −$25.9M | — |
| 2022 | 2022-12-31 | −$139.9M | — | — |
| 2014 | 2014-12-31 | −$23,907 | −$1,173 | — |
| 2013 | 2013-12-31 | −$22,734 | −$393 | — |
| 2012 | 2012-12-31 | −$22,341 | $1,099 | — |
| 2011 | 2011-12-31 | −$23,440 | −$2,931 | — |
| 2010 | 2010-12-31 | −$20,509 | — | — |
Kura Oncology quarterly operating income
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$73.0M | −$344,000 | — |
| Q1 2026 | 2026-03-31 | −$78.8M | −$14.1M | — |
| Q4 2025 | 2025-12-31 | −$86.3M | −$63.8M | — |
| Q3 2025 | 2025-09-30 | −$80.0M | −$20.1M | — |
| Q2 2025 | 2025-06-30 | −$72.7M | −$16.3M | — |
| Q1 2025 | 2025-03-31 | −$64.7M | −$10.2M | — |
| Q4 2024 | 2024-12-31 | −$22.5M | — | — |
| Q3 2024 | 2024-09-30 | −$59.9M | — | — |
| Q2 2024 | 2024-06-30 | −$56.4M | — | — |
| Q1 2024 | 2024-03-31 | −$54.5M | — | — |
| Q4 2014 | 2014-12-31 | −$9,763 | −$1,676 | — |
| Q3 2014 | 2014-09-30 | −$4,764 | −$289 | — |
| Q2 2014 | 2014-06-30 | −$5,242 | $214 | — |
| Q1 2014 | 2014-03-31 | −$4,138 | $578 | — |
| Q4 2013 | 2013-12-31 | −$8,087 | $289 | — |
| Q3 2013 | 2013-09-30 | −$4,475 | $253 | — |
| Q2 2013 | 2013-06-30 | −$5,456 | −$460 | — |
| Q1 2013 | 2013-03-31 | −$4,716 | −$475 | — |
| Q4 2012 | 2012-12-31 | −$8,376 | −$399 | — |
| Q3 2012 | 2012-09-30 | −$4,728 | $632 | — |
| Q2 2012 | 2012-06-30 | −$4,996 | $841 | — |
| Q1 2012 | 2012-03-31 | −$4,241 | $25 | — |
| Q4 2011 | 2011-12-31 | −$7,977 | — | — |
| Q3 2011 | 2011-09-30 | −$5,360 | −$1,122 | — |
| Q2 2011 | 2011-06-30 | −$5,837 | −$716 | — |
| Q1 2011 | 2011-03-31 | −$4,266 | — | — |
| Q3 2010 | 2010-09-30 | −$4,238 | — | — |
| Q2 2010 | 2010-06-30 | −$5,121 | — | — |
Kura Oncology operating income trends
Between the periods ended 2010-12-31 and 2025-12-31, Kura Oncology's operating income decreased from −$20,509 to −$303.6M, a change of −$303.6M. The latest reported quarter, Q2 2026, shows −$73.0M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kura Oncology source filings ↗